Effects of short-term supplementation with ascorbate, folate, and vitamins B6 and B12 on inflammatory factors and estrogen levels in obese postmenopausal women

International Journal for Vitamin and Nutrition Research

Volumn 76, Issue 1, 2006, Pages 34-38

  Palmas, Walter ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

Ascorbic acid; Estrogens; Folic acid; Menopause; Obesity

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; CYANOCOBALAMIN; ESTRADIOL; ESTROGEN; FOLIC ACID; INTERLEUKIN 6; PYRIDOXINE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; OBESITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; VITAMIN SUPPLEMENTATION;

ASCORBIC ACID; C-REACTIVE PROTEIN; DIETARY SUPPLEMENTS; ESTRADIOL; FOLIC ACID; INFLAMMATION; INTERLEUKIN-6; LEPTIN; OBESITY; POSTMENOPAUSE; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 33646231526     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.76.1.34     Document Type: Article

References (31)

1. Gorodeski, G. I. (1994) Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. Exp. Gerontol. 29, 357-375.
2. Schenck-Gustafsson, K. (1996) Risk factors for cardiovascular disease in women: assessment and management. Eur. Heart J. 17 Suppl. D., 2-8.
3. Visser, M., Bouter, L. M., McQuillan, G. M. et al. (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282, 2131-2135.
4. Doshi, S. N., McDowell, I. F., Moat, S. J. et al. (2002) Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105, 22-26.
5. Thambyrajah, J., Landray, M. J., Jones, H. J. et al. (2001) A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. J. Am. Coll. Cardiol. 37, 1858-1863.
6. Willems, F. F., Aengevaeren, W. R., Boers, G. H. et al. (2002) Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J. Am. Coll. Cardiol. 40, 766-772.
7. Heitzer, T., Just, H. and Munzel, T. (1996) Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 94, 6-9.
8. Hornig, B., Arakawa, N., Kohler, C. and Drexler, H. (1998) Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation 97, 363-368.
9. Perticone, F., Ceravolo, R., Candigliota, M. et al. (2001) Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C. Diabetes 50, 159-165.
10. Timimi, F. K., Ting, H. H., Haley, E. A. et al. (1998) Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 31, 552-557.
11. Ting, H. H., Timimi, F. K., Haley, E. A. et al. (1997) Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95, 2617-2622.
12. Carmichael, A. R. and Bates, T. (2004) Obesity and breast cancer: a review of the literature. Breast 13, 85-92.
13. DuBois, R. N. (2004) Aspirin and breast cancer prevention: the estrogen connection. JAMA 291, 2488-2489.
14. Rose, D. P., Komninou, D. and Stephenson, G. D. (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5, 153-165.
15. Dignam, J. J. and Mamounas, E. P. (2004). Obesity and breast cancer prognosis: an expanding body of evidence. Ann. Oncol. 15, 850-851.
16. Laufer, L. R., Davidson, B. J., Ross, R. K. et al. (1983) Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer. Am. J. Obstet. Gynecol. 145, 585-590.
17. Sellers, T. A., Grabrickm D. M., Vierkant, R. A. et al. (2004) Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? Cancer Causes Control 15, 113-120.
18. Sellers, T. A., Kushi, L. H., Cerhan, J. R. et al. (2001) Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology 12, 420-428.
19. Yager, J. D. (2000) Endogenous estrogens as carcinogens through metabolic activation. J. Natl. Cancer Inst. Monogr. 67-73.
20. Zhu, B. T. (2003) Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancer. Int. J. Oncol. 22, 499-508.
21. Siegel, B. V. and Morton, J. I. (1984) Vitamin C and immunity: influence of ascorbate on prostaglandin E2 synthesis and implications for natural killer cell activity. Int. J. Vitam. Nutr. Res. 54, 339-342.
22. Stoll, K. E., Ottino, P. and Duncan, J. R. (1994) Interrelationship of ascorbate, arachidonic acid and prostaglandin E2 in B16 melanoma cells. Prostaglandins Leukot. Essent. Fatty Acids 50, 123-131.
23. Taylor, L., Schneider, E., Smith, J. and Polgar, P. (1981). Prostaglandin production and cellular aging. Mech. Ageing Dev. 16, 311-317.
24. Clyne, C. D., Kovacic, A., Speed, C. J. et al. (2004) Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue. Mol. Cell Endocrinol. 215, 39-44.
25. Zhao, Y., Agarwal, V. R., Mendelson, C. R. and Simpson, E. R. (1996) Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137, 5739-5742.
26. Zhang, S. M. (2004) Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr. Opin. Obstet. Gynecol. 16, 19-25.
27. Ullegaddi, R., Powers, H. J. and Gariballa, S. E. (2004) B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin. Sci. (Lond).
28. 6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial. Eur. J. Clin. Invest. 33, 209-215.
29. Fenton, A. (2003) The demise of HRT? The long-term safety of hormone replacement therapy. Expert Opin. Drug Saf. 2, 341-345.
30. Ryan, A. S. and Nicklas, B. J. (2004) Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care 27, 1699-1705.
31. Tchernof, A., Nolan, A., Sites, C. K. et al. (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105, 564-569.